
    
      This clinical trail includes two phases: basic treatment phase and immunotherapy phase. In
      basic treatment phase, patients will receive concomitant radiation and TMZ-chemotherapy. In
      immunotherapy phase, besides maintenance chemotherapy with TMZ, Fusion cells will be
      administered with IL-12 to enhance the immunity of patients.
    
  